BMC Cancer
(Oct 2018)
Correction to: Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer–testis (CT-X) antigens
Uwe Schirmer,
Heidi Fiegl,
Marco Pfeifer,
Alain G. Zeimet,
Elisabeth Müller-Holzner,
Peter K. Bode,
Verena Tischler,
Peter Altevogt
Affiliations
Uwe Schirmer
Department of Translational Immunology, German Cancer Research Center
Heidi Fiegl
Department of Gynecology and Obstetrics, Medical University of Innsbruck
Marco Pfeifer
Department of Translational Immunology, German Cancer Research Center
Alain G. Zeimet
Department of Gynecology and Obstetrics, Medical University of Innsbruck
Elisabeth Müller-Holzner
Department of Gynecology and Obstetrics, Medical University of Innsbruck
Peter K. Bode
Institute of Surgical Pathology, University Hospital Zürich
Verena Tischler
Institute of Surgical Pathology, University Hospital Zürich
Peter Altevogt
Department of Translational Immunology, German Cancer Research Center
DOI
https://doi.org/10.1186/s12885-018-4928-y
Journal volume & issue
Vol. 18,
no. 1
pp.
1
– 3
Abstract
Read online
Following publication of the original article [1], we have been alerted to errors in Figs. 2 and 8. In Fig. 2B, the GAPDH loading control for Hec1A cells is shown twice in error (in Fig. 2B and Fig. 2C). In Fig. 8, in testis case 1 (first column) the MAGE-A4 staining panel was repeated and also appears as the NY-ESO-1 staining panel in error. The corrected versions of Fig. 2 and Fig. 8 are shown below. We apologize for this inconvenience.
Published in BMC Cancer
ISSN
1471-2407 (Online)
Publisher
BMC
Country of publisher
United Kingdom
LCC subjects
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website
http://bmccancer.biomedcentral.com
About the journal
WeChat QR code
Close